Cannara Biotech GAAP EPS of -$0.01, revenue of $13M

Stock Information for Cannara Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cannara Biotech Inc.

Cannara Biotech to Host Investor Webcast on June 25th, 2025
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.